FCGR2A and neoplasm: As immunization against a panel of tumor-derived Ag turned out to be necessary for successful tumor rejection in different tumor models [9-13,26], we investigated exogenous loading of DC that relies on Ag targeting to FcγR but nevertheless can provide antigenic polyvalency.